Teny M John, MBBS, MD
Department of Infectious Diseases, Infection Control, and Employee Health, Division of Internal Medicine
Present Title & Affiliation
Primary Appointment
Assistant Professor, Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, TX
Dual/Joint/Adjunct Appointment
Assistant Professor, Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, TX
Education & Training
Degree-Granting Education
| 2004 | Government Medical College, Kottayam, IN, Medicine and Surgery, MBBS |
Postgraduate Training
| 2017-2019 | Clinical Fellowship, Infectious Disease, Cleveland Clinic, Cleveland, Ohio |
| 2015-2017 | Clinical Residency, Internal Medicine, Cleveland Clinic, Cleveland, Ohio |
| 2014-2015 | Clinical Internship, Internal Medicine, Cleveland Clinic, Cleveland, Ohio |
| 2007-2010 | Clinical Residency, Internal Medicine, Government Medical College, Kottayam |
Licenses & Certifications
| 2020 | American Board of Infectious Diseases |
| 2020 | Doctor of Medicine |
| 2020 | Texas Medical Board |
| 2020 | Texas Medical Board |
| 2018 | American Academy of HIV Specialist |
| 2018 | American Board of Internal Medicine |
| 2016 | Doctor of Medicine (MD) |
| 2012 | National Board of Examinations (India) |
Experience & Service
Faculty Academic Appointments
Specialist, Infectious Diseases, Hamad Medical Corporation, Doha, 2012 - 2012
Senior Resident, General Internal Medicine, Government Medical College, Kottayam, 2010 - 2011
Administrative Appointments/Responsibilities
Fellowship Program Evaluation Committee member, Infectious Diseases, The University of Texas Health Science Center at Houston, Houston, TX, 2022 - Present
Committee Chair, Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, TX, 2020 - Present
Other Professional Positions
Guideline Committee Member, ASTCT Committee on Practice Guidelines (CPG); Transplant Infectious Disease Special Interest Group (TID-SIG), American Society of Transplantation and Cellular Therapy, 2024 - 2024
ID Metabolites/Direct MALDI Work group member, American Society of Transplantation Biomarker Consensus Conference, Virtual, 2021 - 2022
Junior Registrar, Modern Clinic, Kottayam, 2004 - 2007
Intramural Institutional Committee Activities
Member, Credentials Committee of the Medical Staff (CCMS), The University of Texas MD Anderson Cancer Center, 2025 - 2028
Member, Immuno Oncology Toxicity (IOTOX) working group, The University of Texas MD Anderson Cancer Center, 2025 - Present
Chair, Weekly Infectious Diseases CME committee, The University of Texas MD Anderson Cancer Center, 2020 - Present
Extramural Institutional Committee Activities
Chair elect, Junior Faculty Committee, The University of Texas MD Anderson Cancer Center, 2024 - 2026
Member, Junior Faculty Committee, The University of Texas MD Anderson Cancer Center, 2022 - Present
Senator, Infectious Diseases, UT MD Anderson Faculty Senate, The University of Texas MD Anderson Cancer Center, 2020 - 2025
Resident/Fellow member, Cleveland Clinic community acquired pneumonia care path, The University of Texas MD Anderson Cancer Center, 2015 - 2016
Editorial Activities
Reviewing Editor, Spectrum, 2022 - Present
Review Editor, Frontiers in Fungal Biology, 2022 - Present
Honors & Awards
| 2018 | ID week travel grant, Infectious Disease Society of America |
| 2018 | Member of Royal College of Physicians of UK, Royal College of Physicians of UK |
Professional Memberships
Selected Presentations & Talks
Local Presentations
- 2026. Breath Biomarkers for the Prediction of Cytokine Release Syndrome and Neurotoxicity in Patients Receiving Chimeric Antigen Receptor–Modified T-cell Therapy –a proof-of-concept study. Invited. Department of Internal Medicine Research Grandrounds. Houston, Texas, US.
Regional Presentations
- 2021. Path to Normalcy: Role of Vaccines. Conference. Path to Normalcy: Role of Vaccines. Virtual, US.
- 2010. Tuberculosis in chronic kidney disease - a descriptive study. Conference. Tuberculosis in chronic kidney disease - a descriptive study. Vayanadu, IN.
- 2008. A case of Takayasu arteritis presenting as Fever of Unknown Origin. Conference. A case of Takayasu arteritis presenting as Fever of Unknown Origin. Kottayam, IN.
National Presentations
- 2023. Breath Biomarkers for the Early Diagnosis and Prediction of Cytokine Release Syndrome in Patients Receiving Chimeric Antigen Receptor–Modified T-cell Therapy –a proof-of-concept study. Conference. Breath Biomarkers for the Early Diagnosis and Prediction of Cytokine Release Syndrome in Patients Receiving Chimeric Antigen Receptor–Modified T-cell Therapy –a proof-of-concept study, US.
- 2018. Volatile Organic Compounds Patterns in Breath, Plasma, and Stool in Patients with Clostridium difficile Infection – A Cross-sectional Proof of Concept Study. Conference. Volatile Organic Compounds Patterns in Breath, Plasma, and Stool in Patients with Clostridium difficile Infection – A Cross-sectional Proof of Concept Study. San Francisco, CA, US.
- 2018. Escherichia Coli Community Acquired Pneumonia. Conference. Escherichia Coli Community Acquired Pneumonia. San Francisco, US.
- 2016. Combination Antifungal Therapy for Invasive Aspergillosis among Patients with Hematopoietic Cell Transplantation and Positive Galactomannan. Conference. Combination Antifungal Therapy for Invasive Aspergillosis among Patients with Hematopoietic Cell Transplantation and Positive Galactomannan. New Orleans, LA, US.
- 2015. Profile of Tuberculosis (TB) presenting as immune reconstitution syndrome in HIV patients on highly active anti-retroviral treatment (HAART). Conference. Profile of Tuberculosis (TB) presenting as immune reconstitution syndrome in HIV patients on highly active anti-retroviral treatment (HAART). San Diego, CA, US.
- 2012. Disseminated Cutaneous and subcutaneous Rhinosporidiosis – a case series study from South India. Conference. Disseminated Cutaneous and subcutaneous Rhinosporidiosis – a case series study from South India. San Diego, CA, US.
- 2011. Clinico Mycological Study on the Pattern of Dermatophytic Infections in Central Kerala, South India. Conference. Clinico Mycological Study on the Pattern of Dermatophytic Infections in Central Kerala, South India. Boston, MA, US.
International Presentations
- 2026. Clinical Utility of Targeted Metagenomic Sequencing Versus Multiplex PCR in Pneumonia Among Patients With Hematologic Malignancies. Invited. The European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Global 2026. Basel, CH.
- 2025. Breath Biomarkers for Predicting Cytokine Release Syndrome and Immune Effector Cell-Associated Neurotoxicity Syndrome in Chimeric Antigen Receptor T-cell Therapy Recipients. Invited. Breath Summit 2025. Innsbruck, AT.
- 2024. Disseminated histoplasmosis in a patient with myelofibrosis on ruxolitinib. Invited. 34th European Congress of Clinical Microbiology and Infectious Diseases. Barcelona, ES.
- 2021. Mucormysosis in COVID survivors- the beginning of a new challenge!. Invited. Mucormysosis in COVID survivors- the beginning of a new challenge!. New Delhi, IN.
- 2020. Volatile Compound Analysis of Breath from Patients with Clostridium difficile Infection for Biomarker Discovery and Biological Insight. Invited. Volatile Compound Analysis of Breath from Patients with Clostridium difficile Infection for Biomarker Discovery and Biological Insight. Cambridge, GB.
- 2014. The impact of 3 step algorithm for the detection of Clostridium difficile infection on Infection control Practices in the State of Qatar. Conference. The impact of 3 step algorithm for the detection of Clostridium difficile infection on Infection control Practices in the State of Qatar. Qatar, QA.
- 2011. Leprosy presenting as Immune reconstitution Inflammatory Syndrome (IRIS) in patients on Highly Active Anti-Retroviral Treatment (HAART)—A case series study from a tertiary care centre in Kerala, South India. Conference. Leprosy presenting as Immune reconstitution Inflammatory Syndrome (IRIS) in patients on Highly Active Anti-Retroviral Treatment (HAART)—A case series study from a tertiary care centre in Kerala, South India. Vienna, AT.
- 2011. Uncommon syndrome secondary to sepsis with an uncommon pathogen. Conference. Uncommon syndrome secondary to sepsis with an uncommon pathogen. Vienna, Austria, AT.
- 2010. Clinical profile of Tuberculosis in Chronic Kidney Disease. Conference. Clinical profile of Tuberculosis in Chronic Kidney Disease. Vancouver, CA.
Grant & Contract Support
| Date: | 2026 - Present |
| Title: | Predictive Risk modeling using Integrated Multi-omics and Ensemble learning in Cellular Immunotherapy-related Toxicities |
| Funding Source: | Department of Defense |
| Role: | PI |
| Date: | 2026 - Present |
| Title: | Breath biomarkers-based Risk Evaluation of Adverse Toxicities in patients with Hematologic cancers receiving Cellular Immuno Therapy |
| Funding Source: | Elsa U Pardee Foundation |
| Role: | PI |
| Date: | 2025 - Present |
| Title: | MUCOR-ADVANCE - Deciphering Immunopathogenesis of MUCORmycosis to ADVANCE Risk Stratification, Diagnosis and Management of the Disease |
| Funding Source: | NIH |
| Role: | Co-I |
| ID: | P01AI186818 |
| Date: | 2025 - Present |
| Title: | PRIME CI: Predictive Risk modeling using Integrated Multi-omics and Ensemble learning in Cellular Immunotherapy |
| Funding Source: | NIH |
| Role: | PI |
| Date: | 2025 - 2025 |
| Title: | A multi-modal biomarker test for predicting CAR T-cell associated toxicities |
| Funding Source: | CPRIT |
| Role: | PI |
| ID: | RP260066 |
| Date: | 2023 - 2025 |
| Title: | A Phase 3, Multicenter, Prospective, Randomized, Double-blind Study of Two Treatment Regimens for Candidemia and/or Invasive Candidiasis: Intravenous Echinocandin followed by Oral Ibrexafungerp versus Intravenous Echinocandin followed by Oral Fluconazole |
| Funding Source: | Scynexis |
| Role: | PI |
| Date: | 2022 - 2024 |
| Title: | Breath Biomarkers for the Early Diagnosis and Prediction of Cytokine Release Syndrome in Patients Receiving Chimeric Antigen Receptor–Modified T-cell Therapy –a proof-of-concept study |
| Funding Source: | Health and Environmental Sciences Institute |
| Role: | PI |
| ID: | HESI THRIVE |
| Date: | 2021 - Present |
| Title: | The utility of clinical metagenomics compared to panel-based molecular diagnostics in hematological malignancy and stem cell transplant patients with pneumonia |
| Funding Source: | Illumina |
| Role: | PI |
| Date: | 2018 - 2019 |
| Title: | Volatile Organic Compounds in breath, plasma and stool in Clostiridium difficile infection |
| Funding Source: | Cleveland Clinic Lerner Research Center |
| Role: | PI |
| ID: | RPC 290 S2 |
| Title: | BREATH-CART : Breath Exhalate Analysis for Toxicities, Host microbiome Effects in CAR T-cell therapy |
| Funding Source: | NIH |
| Role: | PI |
| Title: | Proteomic Risk Estimation and Dynamic Immune Characterization for Toxicity in CAR T-cell therapy |
| Funding Source: | CPRIT |
| Role: | PI |
Selected Publications
Peer-Reviewed Articles
- Irajizad E, Fahrmann JF, Katayama H, Strati P, Nair R, Chihara D, Fayad LE, Ahmed S, Iyer SP, Wang M, Locke FL, Davila M, Flowers CR, Shpall E, Neelapu SS, Hanash S, Westin J, Jain MD, John TM, Saini NY. A circulating protein signature for predicting severe immune-related adverse events following CAR T-cell therapy in relapsed/refractory lymphoma. medRxiv. e-Pub 2026.
- Grippin, A, Marconi, C, Copling, S, Li, N, Braun, C, Rooney, M, Schrank, B, Gladish, G, Vaporciyan, AA, Johns, AC, Subbiah, IM, Aloia, TA, Wu, J, Wu, CC, Woodman, SE, Weinstein, JN, Tawbi, H, Shete, S, Scheet, PA, Ravi, V, Palaskas, NL, Nates, JL, Muthu, M, Musunuru, TN, McEnery, KW, Litton, J, John, TM, Jaffray, D, Hutcheson, KA, Gunther, J, Godoy, M, Futreal, A, French, KE, Draetta, G, Dabaja, BS, Crommett, JW, Cata, JP, Brock, K, Beird, H, Aaroe, AE, Lee, JJ, Sun, R, Sharma, P, Tran, HT, Zhang, J, Gibbons, DL, Wargo, J, Heymach, JV, Jiang, W, Lin, SH. SARS-CoV-2 mRNA vaccines sensitize tumours to immune checkpoint blockade. Nature 647(8089):488-497, 2025. e-Pub 2025. PMID: 41125896.
- Smith DJ, Murphy HR, Benedict K, Dailey Garnes NJM, Vuong NN, Harris AH, John TM. Trends in antifungal use among hospitalized patients in the USA, 2018-23. J Antimicrob Chemother 80(10):2659-2664, 2025. e-Pub 2025. PMID: 40795934.
- Makhoul J, Chiu C, Berthelot C, Mays SR, Bose P, John TM. Ruxolitinib Meets a Forgotten Malady. Clin Infect Dis 81(2):355-357, 2025. e-Pub 2025. PMID: 40971899.
- Douglas, AP, Lamoth, F, John, TM, Groll, A, Shigle, TL, Papanicolaou, GA, Chemaly, RF, Carpenter, P, Dadwal, SS, Walsh, TJ, Kontoyiannis, DP. American Society of Transplantation and Cellular Therapy Series. Transplantation and Cellular Therapy 31(4):194-223, 2025. e-Pub 2025. PMID: 39923936.
- Dagher, H, Chaftari, AP, Hachem, RY, Jiang, Y, Philip, A, Mulanovich, P, Haddad, AJ, Lamie, PM, Dib, RW, John, TM, Dailey Garnes, NM, Ali, S, Chaftari, P, Raad, II. Procalcitonin Level Monitoring in Antibiotic De-Escalation and Stewardship Program for Patients with Cancer and Febrile Neutropenia. Cancers 16(20), 2024. e-Pub 2024. PMID: 39456544.
- Chaftari, AP, Dagher, H, Hachem, RY, Jiang, Y, Lamie, PM, Dib, RW, John, TM, Haddad, AJ, Philip, A, Alii, S, Mulanovich, P, Yuan, Y, Chaftari, P, Raad, II. A randomized non-inferiority study comparing imipenem/cilastatin/relebactam with standard-of-care Gram-negative coverage in cancer patients with febrile neutropenia. Journal of Antimicrobial Chemotherapy 79(10):2543-2553, 2024. e-Pub 2024. PMID: 39092963.
- Moni, M, Sathyapalan, DT, Edathadathil, F, Razak, MA, Nair, SG, Nair, CV, Samban, SS, Prasanna, P, Kulirankal, KG, Purushothaman, SS, Gutjahr, G, Jiang, Y, John, TM. Predicting COVID 19–Associated Pulmonary Aspergillosis Risk in Low- and Middle-Income Countries. Open Forum Infectious Diseases 11(7), 2024. e-Pub 2024. PMID: 39070046.
- John, TM, Shrestha, N, Hasan, L, Pappan, K, Birch, O, Grove, D, Boyle, B, Allsworth, M, Shrestha, P, Procop, GW, Dweik, R. Detection of Clostridioides difficile infection by assessment of exhaled breath volatile organic compounds. Journal of Breath Research 18(2), 2024. e-Pub 2024. PMID: 38502958.
- Zhang, L, San Valentin, ED, John, TM, Jenq, RR, Do, K, Hanna, EY, Peterson, CB, Reyes-Gibby, CC. Influence of oral microbiome on longitudinal patterns of oral mucositis severity in patients with squamous cell carcinoma of the head and neck. Cancer 130(1):150-161, 2024. e-Pub 2024. PMID: 37688396.
- Franklin, A, John, TM, Khawaja, F, Jiang, Y, Yepez, E, Ahuja, J, Faiz, S, Bashoura, L, Sheshadri, A, Shannon, VR, Balachandran, D, Mcconn, KK, Mulanovich, VE, Bhatti, MM, Chemaly, RF. Utility of Bronchoalveolar Lavage for the Diagnosis and Management of COVID-19 in Patients with Cancer. Journal of Infectious Diseases 228(11):1549-1558, 2023. e-Pub 2023. PMID: 37983000.
- Noh, S, Bertini, CD, Mira-Avendano, I, Kaous, M, Patel, B, Faiz, S, Shannon, VR, Balachandran, D, Bashoura, L, Adachi, R, Evans, S, Dickey, BF, Wu, CC, Shroff, G, Manzano, JM, Granwehr, BP, Holloway, S, Dickson, KB, Mohammed, AD, Muthu, M, Song, H, Aroe, A, Aloia, TA, Lee Andrews, II, Badami, KK, Beird, H, Brock, K, Cata, JP, Dabaja, BS, Draetta, G, French, KE, Godoy, M, Hutcheson, KA, Jaffray, D, John, TM, Lee, JJ, Litton, J, McEnery, KW, Musunuru, TN, Nates, JL, Palaskas, NL, Ravi, V, Scheet, PA, Shete, S, Subbiah, IM, Tawbi, H, Woodman, SE, Chung, C, Khawaja, F, Sheshadri, A. Interstitial lung abnormalities after hospitalization for COVID-19 in patients with cancer. Cancer medicine 12(17):17753-17765, 2023. e-Pub 2023. PMID: 37592894.
- Reddy, DS, Cuenca, JA, Botdorf, JS, Muthu, M, Hanmandlu, A, Wegner, RC, Crommett, JW, Gutierrez, C, Rathi, N, Sajith, B, Knafl, M, Abbas, HA, Woodman, SE, Nates, JL, Aaroe, AE, Aloia, TA, Andrews, L, Badami, KK, Baganz, JA, Bajwa, P, Baker, LR, Barbosa, GR, Beird, H, Bourgeois, M, Brock, K, Burton, EM, Cata, JP, Chung, C, Cutherell, M, Dabaja, BS, Draetta, G, French, KE, Futreal, A, Gibbons, C, Godoy, M, Gunther, J, Hutcheson, KA, Jaffray, D, John, TM, Lee, JJ, Litton, J, McEnery, KW, Palaskas, NL, Ravi, V, Scheet, PA, Schmidt, S, Subbiah, IM, Tawbi, H, Wu, J, Yao, JC. Clinical Characteristics and Cause of Death Among Hospitalized Decedents With Cancer and COVID-19. Mayo Clinic Proceedings 98(3):451-457, 2023. e-Pub 2023. PMID: 36868753.
- Dagher H, Chaftari AM, Subbiah IM, Malek AE, Jiang Y, Lamie P, Granwehr B, John T, Yepez E, Borjan J, Reyes-Gibby C, Flores M, Khawaja F, Pande M, Ali N, Rojo R, Karp DD, Chaftari P, Hachem R, Raad II. Long COVID in cancer patients: preponderance of symptoms in majority of patients over long time period. Elife 12, 2023. e-Pub 2023. PMID: 36748905.
- Raad II, Hachem R, Masayuki N, Datoguia T, Dagher H, Jiang Y, Subbiah V, Siddiqui B, Bayle A, Somer R, Fernández Cruz A, Gorak E, Bhinder A, Mori N, Hamerschlak N, Shelanski S, Dragovich T, Vong Kiat YE, Fakhreddine S, Pierre AH, Chemaly RF, Mulanovich V, Adachi J, Borjan J, Khawaja F, Granwehr B, John T, Yepez EY, Torres HA, Ammakkanavar NR, Yibirin M, Reyes-Gibby CC, Pande M, Ali N, Rojo RD, Ali SM, Deeba RE, Chaftari P, Matsuo T, Ishikawa K, Hasegawa R, Aguado-Noya R, García AG, Puchol CT, Lee DG, Slavin M, Teh B, Arias CA, (D3CODE) Team DDFCODE, Kontoyiannis DP, Malek AE, Chaftari AM. International multicenter study comparing COVID-19 in patients with cancer to patients without cancer: Impact of risk factors and treatment modalities on survivorship. Elife 12, 2023. e-Pub 2023. PMID: 36715684.
- Azar MM, Turbett S, Gaston D, Gitman M, Razonable R, Koo S, Hanson K, Kotton C, Silveira F, Banach DB, Basu SS, Bhaskaran A, Danziger-Isakov L, Bard JD, Gandhi R, Hanisch B, John TM, Odom John AR, Letourneau AR, Luong ML, Maron G, Miller S, Prinzi A, Schwartz I, Simner P, Kumar D, Working Group TIDCC. A consensus conference to define the utility of advanced infectious disease diagnostics in solid organ transplant recipients. Am J Transplant 22(12):3150-3169, 2022. e-Pub 2022. PMID: 35822346.
- Raad I, Hachem R, Masayuki N, Datoguia T, Dagher H, Jiang Y, Subbiah V, Siddiqui B, Bayle A, Somer R, Cruz AF, Gorak E, Bhinder A, Mori N, Hamerschlak N, Shelanski S, Dragivich T, Kiat YEV, Fakhreddine S, Hanna PA, Chemaly RF, Mulanovich V, Adachi J, Borjan J, Khawaja F, Granwehr B, John T, Guevara EY, Torres H, Ammakkanavar NR, Yibirin M, Reyes-Gibby CC, Pande M, Ali N, Rojo RD, Ali SM, Deeba RE, Chaftari P, Matsuo T, Ishikawa K, Hasegawa R, Aguado-Noya R, Á G, Puchol CT, Lee DG, Slavin M, Teh B, Arias CA, (D3CODE) Team DDFCODE, Kontoyiannis DP, Malek AE, Chaftari AM. International Multicenter Study Comparing Cancer to Non-Cancer Patients with COVID-19: Impact of Risk Factors and Treatment Modalities on Survivorship. medRxiv, 2022. e-Pub 2022. PMID: 36097568.
- Skaria J, John TM, Varkey S, Kontoyiannis DP. Are Unique Regional Factors the Missing Link in India's COVID-19-Associated Mucormycosis Crisis?. mBio 13(2):e0047322, 2022. e-Pub 2022. PMID: 35357212.
- John TM, Deshpande A, Brizendine K, Yu PC, Rothberg MB. Epidemiology and Outcomes of Community-acquired Escherichia coli Pneumonia. Open Forum Infect Dis 9(1):ofab597, 2022. e-Pub 2022. PMID: 34988258.
- John TM, Shrestha NK, Procop GW, Grove D, Leal SM, Jacob CN, Butler R, Dweik R. Diagnosis of Clostridioides difficile infection by analysis of volatile organic compounds in breath, plasma, and stool: A cross-sectional proof-of-concept study. PLoS One 16(8):e0256259, 2021. e-Pub 2021. PMID: 34407120.
- Leal SM, Popowitch EB, Levinson KJ, John TM, Lehman B, Rios MB, Gilligan PH, Miller MB. Quantitative Thresholds Enable Accurate Identification of Clostridium difficile Infection by the Luminex xTAG Gastrointestinal Pathogen Panel. J Clin Microbiol 56(6), 2018. e-Pub 2018. PMID: 29643194.
- Jacob CN, John TM, R J. Geographic tongue. Cleve Clin J Med 83(8):565-6, 2016. e-Pub 2016. PMID: 27505875.
- John TM, Jacob CN, Xavier J, Kondanath S, Ittycheria CC, Jayaprakash R. A case of acute onset parkinsonism. Qatar Med J 2013(2):29-32, 2013. e-Pub 2013. PMID: 25003061.
- John TM, Jacob CN, Ittycheria CC, George AM, Jacob AG, Subramaniyam S, Puthiyaveettil J, Jayaprakash R. Macrophage activation syndrome following Acinetobacter baumannii sepsis. Int J Infect Dis 16(3):e223-4, 2012. e-Pub 2012. PMID: 22285540.
- Anoop TM, John TM, Fukunaga N. Pseudomyxoma peritonei. Indian J Surg 72(Suppl 1):353-4, 2010. e-Pub 2010. PMID: 23133297.
Invited Articles
- John TM, Taege AJ. Appropriate laboratory testing in Lyme disease. Cleve Clin J Med 86(11):751-759, 2019. e-Pub 2019. PMID: 31710588.
Review Articles
- Allos H, John TM, Stewart A. Microbial cell-free DNA for diagnosis of bacterial and fungal infection in the immunocompromised host - what do we know?. Current Opinion in Infectious Diseases, 2025. e-Pub 2025. PMID: 40920330.
- Babady NE, Chiu CY, Craney A, Gaston DC, Hicklen RS, Hogan CA, John TM, Stewart AG. Diagnosis and management of invasive fungal diseases by next-generation sequencing: are we there yet?. Expert Rev Mol Diagn 24(12):1-14, 2024. e-Pub 2024. PMID: 39623670.
- Chiu, CY, John, TM, Matsuo, T, Wurster, ST, Hicklen, RS, Khattak, RR, Ariza Heredia, E, Bose, P, Kontoyiannis, DP. Disseminated Histoplasmosis in a Patient with Myelofibrosis on Ruxolitinib. Journal of Fungi 10(4), 2024. e-Pub 2024. PMID: 38667935.
- John TM, Jacob CN, Kontoyiannis DP. When Uncontrolled Diabetes Mellitus and Severe COVID-19 Converge: The Perfect Storm for Mucormycosis. J Fungi (Basel) 7(4), 2021. e-Pub 2021. PMID: 33920755.
Abstracts
- Merlin M, Teny MJ, Abdul RM, Kiran GK, Fabia E, Dipu TS. Conference abstract. OFID 9:Supplement_2, pp. ofac492-372, 2022. e-Pub 2022.
- John, TM, Deshpande, A, Haessler, S, Brizendine, K, Yu, PC, Imrey, P, Rothberg, MB. Escherichia coli Community Acquired Pneumonia. Open Forum Infectious Diseases(suppl_1):S451-S451, 2018. e-Pub 2018.
- John, T, Shrestha, N, Procop, G, Grove, D, Leal, S, Jacob, C, Butler, R, Dweik, R. Volatile Organic Compounds Patterns in Breath, Plasma, and Stool in Patients withClostridium difficileInfection: A Cross-Sectional Proof of Concept Study. Open Forum Infectious Diseases 5:S585, 2018. e-Pub 2018.
- TM John TM, K Brizendine K. Combination Antifungal Therapy for Invasive Aspergillosis Among Patients with Hematopoietic Cell Transplantation and Positive Galactomannan. Open Forum Infectious Diseases 3(suppl_1):1631, 2016. e-Pub 2016.
- CN Jacob CN, TM John TM, R Jayaprakash R, S Kurian S. Profile of Tuberculosis Related Immune Reconstitution Syndrome in HIV Patients on Highly Active Anti-Retroviral Treatment: A Retrospective Study From South India. Open Forum Infectious Diseases 2(suppl_1), 2015. e-Pub 2015.
- AG Jacob AG, AM George AM, T John T. Rheumatoid pleurisy presenting as black pleural effusion. Chest 146(4):471A, 2014. e-Pub 2014.
- AG Jacob AG, AM George AM, T John T. Rhabdomyolysis Induced Renal Failure Secondary to Dual Infection With Influenza A and Legionella pneumophilia. Chest 146(4):281A, 2014. e-Pub 2014.
Book Chapters
- Francisco JMC, Fatima A, Ceena NJ, Teny MJ. Infections in the immunocompromised host. In: Critical Care Medicine Review: 1000 Questions and Answers. 1. Wolters Kluwer Health, Chapter 71; p. 1136, 2019.
- John TM, Granwehr B. Fungal Infections in Patients with Cancer. In: The MD Anderson Manual of Medical Oncology. McGraw Hill.
Letters to the Editor
- John TM, Kontoyiannis DP. Do Not Forget Daptomycin as a Cause of Eosinophilic Pneumonia!. Chest 159: 1687-1688, 2021.
- John TM, Malek AE, Mulanovich VE, Adachi JA, Raad II, Hamilton AR, Shpall EJ, Rezvani K, Aitken SL, Jain N, Klein K, Martinez F, Jacob CN, Cherian SV, Manzano JM, Muthu M, Wegner R. Migratory Pulmonary Infiltrates in a Patient with COVID-19 Infection and the Role of Corticosteroids. Mayo Clin Proc 95: P2038-2040, 2020.
Patient Reviews
CV information above last modified August 20, 2026